Testimony of Dr. Jennifer Yttri at FDA Advisory Committee on tivozanib -

Patients with kidney cancer have many options for drug therapy but often experience bad side effects. As the FDA considers another drug option, we don’t think the science is good enough to suggest patients will have a longer and better quality life on this new drug. Instead, we recommend waiting for more clinical data to give doctors and patients a clear idea of when tivozanib would be beneficial rather than cause more harm.

Radiation and thyroid cancer -

Recent media reports have raised fears that radiation from dental x-rays and mammograms increase the risk of thyroid cancer. Is it true that dental x-rays and mammograms are to blame for the increase in thyroid cancer? Can a simple thyroid shield (an optional extension of the lead apron that blocks x-rays from reaching the neck) reduce the risk and put fears to rest?